ICU Girisim (Turkey) Performance
| ICUGS Stock | 27.58 0.60 2.22% |
ICU Girisim has a performance score of 2 on a scale of 0 to 100. The firm retains a Market Volatility (i.e., Beta) of 0.76, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, ICU Girisim's returns are expected to increase less than the market. However, during the bear market, the loss of holding ICU Girisim is expected to be smaller as well. ICU Girisim Sermayesi currently retains a risk of 3.7%. Please check out ICU Girisim maximum drawdown, accumulation distribution, as well as the relationship between the Accumulation Distribution and market facilitation index , to decide if ICU Girisim will be following its current trending patterns.
Risk-Adjusted Performance
2 of 100
Weak | Strong |
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in ICU Girisim Sermayesi are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. Despite fairly strong forward indicators, ICU Girisim is not utilizing all of its potentials. The recent stock price confusion, may contribute to short-horizon losses for the traders. ...more
ICU |
ICU Girisim Relative Risk vs. Return Landscape
If you would invest 2,702 in ICU Girisim Sermayesi on September 19, 2024 and sell it today you would earn a total of 56.00 from holding ICU Girisim Sermayesi or generate 2.07% return on investment over 90 days. ICU Girisim Sermayesi is generating 0.099% of daily returns and assumes 3.7045% volatility on return distribution over the 90 days horizon. Simply put, 32% of stocks are less volatile than ICU, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
ICU Girisim Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for ICU Girisim's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as ICU Girisim Sermayesi, and traders can use it to determine the average amount a ICU Girisim's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.0267
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | ICUGS | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 3.7 actual daily | 32 68% of assets are more volatile |
Expected Return
| 0.1 actual daily | 1 99% of assets have higher returns |
Risk-Adjusted Return
| 0.03 actual daily | 2 98% of assets perform better |
Based on monthly moving average ICU Girisim is performing at about 2% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of ICU Girisim by adding it to a well-diversified portfolio.
Things to note about ICU Girisim Sermayesi performance evaluation
Checking the ongoing alerts about ICU Girisim for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for ICU Girisim Sermayesi help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| ICU Girisim had very high historical volatility over the last 90 days |
- Analyzing ICU Girisim's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether ICU Girisim's stock is overvalued or undervalued compared to its peers.
- Examining ICU Girisim's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating ICU Girisim's management team can have a significant impact on its success or failure. Reviewing the track record and experience of ICU Girisim's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of ICU Girisim's stock. These opinions can provide insight into ICU Girisim's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for ICU Stock analysis
When running ICU Girisim's price analysis, check to measure ICU Girisim's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy ICU Girisim is operating at the current time. Most of ICU Girisim's value examination focuses on studying past and present price action to predict the probability of ICU Girisim's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move ICU Girisim's price. Additionally, you may evaluate how the addition of ICU Girisim to your portfolios can decrease your overall portfolio volatility.
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Premium Stories Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| Pattern Recognition Use different Pattern Recognition models to time the market across multiple global exchanges |